Personalised Cancer Medicine Flashcards 2022
Currently not recommended
- BRCA1 y BRCA2*
- Homologous Recombination Deficiency (HRD)
- p53, PD-1/PDL-1, ATM, BARD1, BRIP1, CHECK1, CHECK2, FAM175A, MRE11A, NBN, PALB2, RAD51C, RAR51D.
The Recommended category is based on currentrecommendations by EMEA and FDA.
1. Oaknin A, Guarch R, Barretina P, et al. Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clin Transl Oncol. 2018 Mar;20(3):274-285. doi: 10.1007/s12094-017-1719-x.